Testing effectiveness (Phase 2)Study completedNCT02965573
What this trial is testing
Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness
Who this might be right for
Myasthenia Gravis
argenx 24